Identifying asymptomatic carriers of the novel coronavirus is crucial in preventing the spread of COVID-19, particularly in healthcare settings. C3G’s Toronto Node has developed several applications for this purpose across various health institutions.
Continue readingSTOP-CoV: Examining COVID-19 vaccination responses across age groups
As the rollout for COVID-19 vaccinations continues across Ontario the C3G Toronto Node has helped establish STOP-CoV (SafeTy and Efficacy of Preventative COVID Vaccines), a province-wide study to examine the differences in COVID-19 vaccine responses between younger and older individuals.
Continue readingRare loss-of-function variants in type IIFN immunity genes are not associated with severe COVID-19
Host genetic factors related to COVID-19 susceptibility and outcomes are of great interest, as their identification could elucidate the mechanisms of SARS-CoV-2 infection and severity, thereby providing clues about potential therapeutic targets.
Continue reading


